CVS Agrees to Pay $36.5 Million to Resolve Whistleblower Claims on Insulin Billing
CVS Settles Whistleblower Claims with $36.5 Million Payment
In a significant legal development, CVS Health is set to pay a settlement amount of $36.5 million to resolve whistleblower allegations involving improper billing practices related to insulin dispensation in the U.S. healthcare system. This settlement follows investigations by the U.S. Attorney's Office for the Southern District of New York, which intervened in multiple qui tam lawsuits raised by whistleblowers.
The whistleblower case was brought to light by Adam Rahimi, a pharmacist who alleged that CVS violated the False Claims Act between 2010 and 2020. Rahimi claimed that CVS misrepresented the amount of insulin dispensed to diabetic patients by reporting a lower
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.